As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role ...
In a first-of-its-kind trial, physicians will review neurofilament test results with patients and decide whether to continue ...
The company said it expects to seek regulatory permission to begin clinical testing of VY1706 in the US and Canada in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback